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RESUMO
Desfechos Hospitalares em Pacientes  
Submetidos a Intervenção Coronária  
Percutânea Primária versus de Resgate
Introdução: Dificuldades de acesso em tempo hábil a centros 
que oferecem intervenção coronária percutânea (ICP) primá-
ria fazem com que a trombólise química seja a modalidade 
de reperfusão predominante em pacientes com infarto com 
supradesnivelamento do segmento ST (IAMCSST) no Brasil. 
Nesse cenário, a ICP de resgate torna-se importante opção 
para pacientes com insucesso na reperfusão. Comparamos os 
desfechos hospitalares dessas duas modalidades de ICP no 
IAMCSST. Métodos: Entre agosto de 2006 e outubro de 2012, 
pacientes consecutivos do Registro Angiocardio, com IAMCSST, 
foram submetidos à ICP primária ou de resgate. Foi compa-
rada a incidência de eventos cardíacos e cerebrovasculares 
adversos maiores (ECCAM) hospitalares. Resultados: Avaliamos 
801 pacientes submetidos a ICP primária (n = 599) ou a ICP 
de resgate (n = 202). No grupo ICP de resgate foi observada 
menor frequência de trombos, oclusões totais, fluxo TIMI 
0/1 pré-procedimento e presença de circulação colateral. O 
ABSTRACT
Background: Difficulties to reach centers that offer primary 
percutaneous coronary intervention (PCI) in a timely manner 
turn intravenous thrombolysis into the predominant reperfu-
sion mode in patients with ST segment elevation myocardial 
infarction (STEMI) in Brazil. In this scenario, rescue PCI be-
comes an important therapeutic option for patients who fail 
reperfusion. We have compared hospital outcomes of these 
two PCI modalities in STEMI. Methods: Between August 2006 
to October 2012, consecutive patients with STEMI enrolled in 
the Angiocardio Registry were submitted to primary or rescue 
PCI. The incidence of in-hospital major adverse cardiac and 
cerebrovascular events (MACCE) was compared. Results: We 
evaluated 801 patients undergoing primary (n = 599) or rescue 
PCI (n = 202). In the rescue PCI group a lower frequency of 
thrombi, total occlusions, pre-procedure TIMI 0/1 flow and 
angiographically detectable collaterals was observed. The use 
of stents was similar, as well as the procedure success rates 
(91.7% vs 90.6%; P = 0.75). The incidence of MACCE (6.3% 
vs 6.9%; P = 0.89), death (4% vs 4%; P > 0.99), stroke (0.3% 
vs 0; P = 0.99) and reinfarction (2.7% vs 3%; P > 0.99) was 
not different between groups. In the multivariate analysis, the 
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presence of dyslipidemia [odds ratio (OR) 2.190, 95% confi-
dence interval (95% CI) 1.14-4.16; P = 0.01], Killip class III or 
IV (OR 7.494, 95% CI 3.90-14.31; P < 0.01) and lesions with 
moderate/severe calcification (OR 2.852, 95% CI 1.39-5.62; 
P < 0.01), were the variables that best explained in-hospital 
MACCE. Conclusions: In this contemporary registry, rescue 








DESCRIPTORS: Myocardial infarction. Angioplasty. Stents. 
Thrombolytic therapy.
of coronary stents was restricted to slightly more than 
half of the studied patients. This study aims at compar-
ing in-hospital outcomes between contemporary primary 
and rescue PCI in STEMI.
METHODS
Patients
This study included consecutive patients from the 
Angiocardio registry with STEMI undergoing primary PCI 
or rescue PCI, from August 2006 to October 2012. This 
registry includes all patients undergoing PCI in Hospital 
Bandeirantes, Hospital Rede D’Or São Luiz – Unidade 
Anália Franco, and Hospital Leforte, all located in 
São Paulo, SP, Brazil; in Hospital Vera Hospital Cruz, 
Campinas, SP, Brazil; and in Hospital Regional Vale do 
Paraíba, Taubaté, SP, Brazil.
The clinical and angiographic characteristics were 
compared, as well as characteristics related to the 
procedure, rates of success, and incidence of MACCE 
at discharge. Data were prospectively collected and 
stored in a computerized database for further analysis.
Percutaneous coronary intervention
The technique, access route, and choice of mate-
rial, including the use of thrombus aspiration catheters 
and glycoprotein IIb/IIIa inhibitors during the procedure, 
were at the discretion of the surgeons. Unfractionated 
heparin was used at a dose of 70 U/kgto 100 U/kg at 
the beginning of the procedure, except in patients who 
were already receiving low molecular-weight heparin. 
In these cases, a dose of 0.3 mg/kg was added intra-
venously, adjusted according to the last dose interval. 
All patients received combined antiplatelet therapy 
with acetylsalicylic acid (dose of 100 to 200 mg/day) 
and clopidogrel (loading dose of 300 to 600 mg, and 
maintenance dose of 75 mg/day).
emprego de stents foi similar, assim como a taxa de sucesso 
do procedimento (91,7% vs. 90,6%; P = 0,75). A incidência 
de ECCAM (6,3% vs. 6,9%; P = 0,89), óbito (4% vs. 4%; P 
> 0,99), acidente vascular cerebral (0,3% vs. 0%; P = 0,99) e 
reinfarto (2,7% vs. 3%; P > 0,99) não diferiu entre os grupos. 
Na análise multivariada, dislipidemia (oddsratio [OR] 2,190; 
intervalo de confiança de 95% [IC 95%] 1,14-4,16; P = 
0,01], classe funcional Killip III ou IV (OR: 7,494; IC 95%: 
3,90-14,31; P < 0,01) e lesões com calcificação moderada/
acentuada (OR: 2,852; IC 95%: 1,39-5,62; P < 0,01) foram 
as variáveis que melhor explicaram os ECCAM hospitalares. 
Conclusões: Neste registro contemporâneo, a ICP de resgate 
obteve resultados hospitalares similares aos da ICP primária.
DESCRITORES: Infarto do miocárdio. Angioplastia. Stents. 
Terapia trombolítica.
A cute myocardial infarction is an important cause of morbidity and mortality throughout the world. In Brazil, in 2010, over 80,000 deaths were re-
corded from acute ischemic heart syndromes.1Blood flow 
return, either by chemical thrombolysis or percutaneous 
coronary intervention (PCI), if performed within the first 
hours of symptom onset, is considered the best strategy 
for the treatment of ST-segment elevation myocardial 
infarction (STEMI), with proven clinical benefits and 
reduced mortality, to approximately 4% to 7%.2-4
Primary PCI, despite the evidence of superiority in 
relation to chemical thrombolysis,5-8 with lower rates 
of major adverse cardiac and cerebrovascular events 
(MACCE) and higher rates of patency in the culprit vessel, 
is not widely available in Brazil. Difficulties to reach 
hospitals that provide the intervention within a timely 
manner result in a relatively low number of primary 
PCIs in this country. It is estimated by the Department 
of Informatics of the Brazilian Unified Health System 
(Departamento de Informática do Sistema Único de 
Saúde - DATASUS) that only 13% to 15% of hospi-
talized patients with STEMI receive primary PCI as a 
reperfusion strategy. Although data from the National 
Cardiovascular Intervention Center (Central Nacional 
de Intervenções Cardiovasculares – CENIC) show a 
progressive increase in primary PCIs between 2006 and 
2010, chemical thrombolysis remains the predominant 
reperfusion modality, used in over 40% of patients with 
STEMI.9 Rescue PCI is mandatory for patients who fail 
post-fibrinolytic reperfusion (segment resolution < 50% 
in 60 minutes), as it reduces the incidence of MACCE, 
when compared with re-thrombolysis or with conserva-
tive treatment.10-12
There have been few reports in Brazil comparing 
primary and rescue PCI strategies, including the publica-
tion by Mattos et al.,13 using data from CENIC between 
1997 and 2000, which showed a higher in-hospital 
mortality for rescue PCI in a sample in which the use 
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Angiographic analysis and definitions
The analyses were performed on at least two 
orthogonal projections by professionals who had ex-
perience with digital quantitative angiography. This 
study used the same angiographic criteria as CENIC. 
The American College of Cardiology/American Heart 
Association criteria were used to identify the type of 
lesion.4 Lesions were considered long when their length 
was > 20 mm. Thrombolysis in Myocardial Infarction 
(TIMI) classification was used to classify pre- and 
post-procedure coronary flow.14 The rate of procedural 
success was defined as attaining angiographic success 
(residual stenosis < 30%, with TIMI 3 flow) and absence 
of MACCE, comprising death, stroke, reinfarction, and 
emergency coronary artery bypass graft (CABG) surgery. 
Reinfarction was defined by the presence of new is-
chemic electrocardiographic changes and/or alterations 
in laboratory markers of myocardial necrosis and/or 
angiographic evidence of vessel-target occlusion. The 
overall mortality was considered for the analysis (death 
from any cause) during the hospitalization period.
Statistical Analysis
The data were stored in an Oracle-based Coreangio 
database, plotted on Excel spread sheets, and analyzed 
using SPSS software, version 15.0. Continuous variables 
were expressed as means and standard deviations, and 
categorical variables as absolute numbers and percent-
ages. The associations between continuous variables 
were evaluated using the analysis of variance (ANOVA) 






Age, years 61.3 ± 13.1 57.9 ± 11.8 < 0.01
Male gender, n (%) 425 (71) 143 (70.8) > 0.99
Smoking, n (%) 174 (29) 67 (33.2) 0.31
Arterial hypertension, n (%) 411 (68.6) 143 (70.8) 0.62
Dyslipidemia, n (%) 162 (27) 46 (22.8) 0.26
Diabetes, n (%) 143 (23.9) 44 (21.8) 0.60
Previous myocardial infarction, n (%) 60 (10) 17 (8.4) 0.59
Previous coronary artery bypass graft surgery, n (%) 26 (4.3) 2 (1) 0.04
Chronic renal failure, n (%) 12 (2) 2 (1) 0.52
Previous stroke, n (%) 13 (2.2) 3 (1.5) 0.75
Previous percutaneous coronary intervention, n (%) 91 (15.2) 27 (13.4) 0.60
Killip, n (%) 0.05
I 434 (75.5) 112 (66.7)
II 77 (13.4) 32 (19)
III 14 (2.4) 9 (5.4)
IV 50 (8.7) 15 (8.9)
Acute myocardial infarction location, n (%) 0.07
Anterior 224 (39) 83 (49.4)
Antero-apical 2 (0.3) 4 (2.4)
Antero-lateral 51 (8.9) 11 (6.5)
Dorsal 3 (0.5) 0 (0)
Inferior 194 (33.7) 49 (29.2)
Infero-dorsal 41 (7.1) 5 (3)
Infero-lateral-dorsal 52 (9) 13 (7.7)
Lateral 8 (1.4) 3 (1.8)
Ganassin et al. 
Primary PCI Versus Rescue
Rev Bras Cardiol Invasiva. 
2013;21(2):133-9
136
model. The associations between categorical variables 
were evaluated by chi-squared test, Fisher’s exact test, 
or likelihood ratio, when appropriate. Significance level 
was set at P <  0.05. Multivariate analysis was used to 
identify independent predictors of MACCE.
RESULTS
The present study evaluated 801 consecutive pa-
tients who underwent primary PCI (n  =  599 patients; 
664 vessels; 719 lesions) or rescue PCI (n = 202; pa-
tients; 218 vessels; 242 lesions). The rescue PCI group 
was, on average, three years younger and had a lower 
incidence of prior revascularization surgery (4.3% vs. 
1%; P = 0.04). There was a tendency in this group of 
patients to have more advanced Killip class (P = 0.05) 
and higher incidence of anterior wall myocardial infarc-
tion (P = 0.07). The groups did not differ regarding the 
other clinical characteristics (Table 1).
Regarding the angiographic characteristics, a strong 
predominance of patients with one-vessel involvement (> 
80%) was observed; the left anterior descending artery 
was the most often affected vessel, especially in the 
rescue PCI group (47.3% vs. 56.4%). Lower frequency of 
lesions with thrombi (45.8% vs. 31.8%; P < 0.01); total 
occlusions (61.9 % vs. 38%; P < 0.01); pre-procedure 
TIMI flow 0/1 (67.7% vs. 40.5%), and the presence of 
collateral circulation (28.7% vs. 16.1%; P < 0.01) was 
observed in patients undergoing rescue PCI (Table 2).
Regarding the characteristics of the procedures 
(Table 3), the rates of stent use were similar (83.1% 
vs. 84.9%, P  = 0.62), with a low rate of drug-eluting 
stent (DES) use, especially in the rescue PCI group 
(7.1% vs. 1.6%; P  = 0.01). Direct stenting was also 
more frequent in this group (24.3% vs. 44.3%; P  < 
0.01). Shorter stents were implanted in the rescue 
PCI group (20.8 mm vs. 19.5 mm, P = 0.01), with no 
differences between groups regarding stent diameter. 







vessels/ n = 242 lesions P-value
Coronary disease extent, n (%) 0.49
One-vessel 496 (82.8) 171 (84.7)
Two-vessel 88 (14.7) 23 (11.4)
Three-vessel 13 (2.2) 7 (3.5)
Multivessel 2 (0.3) 1 (0.5)
Treated vessels, n (%) 0.03
Left anterior descending artery 314 (47.3) 123 (56.4)
Left circumflex artery 99 (14.9) 20 (9.2)
Right coronary artery 236 (35.5) 73 (33.5)
Left main coronary artery 3 (0.5) 0
Grafts 12 (1.8) 2 (0.9)
Type B2/C lesions, n (%) 483 (78.3) 149 (72) 0.07
Calcified lesions, n (%) 365 (50.9) 113 (46.7) 0.29
Moderate/severe calcification, n (%) 105 (14.6) 25 (10.3) 0.11
Thrombotic lesions, n (%) 329 (45.8) 77 (31.8) < 0.01
Lesions > 20 mm, n (%) 84 (11.7) 25 (10.3) 0.64
Bifurcation lesions, n (%) 51 (7.1) 11 (4.5) 0.21
Total occlusions, n (%) 445 (61.9) 92 (38) < 0.01
Pre-procedure TIMI, n (%) < 0.01
0/1 487 (67.7) 98 (40.5)
2/3 232 (32.3) 144 (59.5)
Collateral circulation, n (%) 206 (28.7) 39 (16.1) < 0.01
TIMI, Thrombolysis in Myocardial Infarction.
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A lower degree of pre-procedure lesion stenosis was 
also observed in this same group (95.2% vs. 90.7%; 
P < 0.01), and glycoprotein IIb/IIIa inhibitors were used 
less frequently (68.3% vs. 4%; P  < 0.01), as well as 
thrombus aspiration catheters (21.8% vs. 5.7%; P < 
0.01). The procedure success rates were similar and > 
90% in both groups.
The incidence of MACCE (6.3% vs. 6.9%; P  = 
0.89), in-hospital death (4% vs. 4%; P > 0.99), stroke 
(0.3 % vs. 0; P = 0.99), and reinfarction (2.7% vs. 3%; 
P > 0.99) did not differ between the groups. There were 
no cases of emergency CABG in the sample (Table 4).
In the univariate analysis, the variables age, smok-
ing, dyslipidemia, presence of lesions with moderate/
severe calcification, prior CABG, chronic renal failure, 
Killip class III or IV, and use of IIb/IIIa glycoprotein 
inhibitors showed a significant association with the 
occurrence of MACCE. In the multivariate analysis, the 
presence of dyslipidemia (odds ratio [OR], 2.190; 95 % 
confidence interval [95% CI], 1.14 to 4.16; P = 0.01], 
Killip functional class III or IV (OR, 7.494; 95% CI, 
3.90 to 14.31; P  < 0.01), and lesions with moderate/
severe calcification (OR, 2.852; 95% CI, 1.39 to 5.62; 
P  <  0.01) were the variables that best explained the 
presence of in-hospital MACCE (Table 5).
DISCUSSION
This study compared in-hospital outcomes between 
contemporary primary and rescue PCI in STEMI. The 
findings showed that the occurrence of MACCE was 
low and similar between groups, with an in-hospital 
mortality rate of 4%. Similar mortality rates have been 
recently published in the Strategic Reperfusion (With 
Tenecteplase and Antithrombotic Treatment) Early After 
Myocardial Infarction (STREAM) study in patients with 
less than three hours of STEMI symptom onset submitted 
to primary PCI strategy or to pharmaco invasive strategy 
with the use of tenecteplase and transfer to PCI (4.4% 
and 4.6%, respectively).14
Previous reports have demonstrated higher mortality 
(6% to 8%) in patients undergoing rescue PCI in rela-
tion to primary PCI.13,15,16 In Brazil, Mattos et al.,13with 
data collected from the CENIC registry, evaluated 9,371 
patients and also demonstrated higher mortality of res-
cue PCI compared with primary PCI (7.4% vs. 5.6%; 
P = 0.034). Conversely, Baer et al.17 showed similar 
results between the two modalities, concluding that 
the rescue intervention is the mandatory procedure for 
the treatment of STEMI, when chemical thrombolysis 
failure occurs. It is noteworthy that these publications 
showed a low rate of stenting (< 60 %) compared 







vessels/ n = 242 lesions P-value
Treated vessels/patient 1.20 ± 0.48 1.20 ± 0.51 0.92
Implanted stents, n (%) 513 (85.6) 175 (86.6) 0.81
Stent/patient ratio, n (%) 1.06 ± 0.62 1.00 ± 0.54 0.24
Stent use, n (%) 552 (83.1) 185 (84.3) 0.62
Drug-eluting stents, n (%) 39 (7.1) 3 (1.6) 0.01
Direct-stenting technique, n (%) 134 (24.3) 82 (44.3) < 0.01
Stent diameter, mm 3.09 ± 0.48 3.13 ± 0.46 0.27
Stent length, mm 20.8 ± 6.8 19.5 ± 6.5 0.01
Glycoprotein IIb/IIIa inhibitors, n (%) 190 (68.3) 8 (4) < 0.01
Thromboaspiration, n (%) 112 (21.8) 10 (5.7) < 0.01
Post-procedure TIMI flow, n (%) 0.18
0/1 38 (5.5) 19 (8.3)
2/3 652 (94.5) 211 (91.7)
Degree of stenosis, %
Pre 95.2 ± 10.4 90.7 ± 12.4 < 0.01
Post 7.3 ± 22.8 9.1 ± 26.4 0.36
Procedural success 549 (91.7) 183 (90.6) 0.75
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to current rates of contemporary PCI. In the present 
series, the use of stenting in both groups occurred in 
over 80% patients. Previous studies have shown that 
stenting (DES and BMS) favourably affects the prognosis 
of patients with STEMI, promoting TIMI coronary flow 
improvement, with lower rates of ventricular dysfunc-
tion and mortality.18-20
Previous use of fibrinolytics in the rescue PCI 
group probably explains the lower thrombotic bur-
den of the lesions and lower frequency of catheter 
use for thrombus aspiration and glycoprotein IIb/IIIa 
inhibitors, in addition to the decreased use of the 
direct stenting technique in the present sample. It also 
explains the higher incidence of TIMI 2/3 before the 
procedure, which is associated with better prognosis 
in patients with STEMI.21,22 The Plasminogen-activator 
– Angioplasty Compatibility Trial (PACT),23 which 
compared patients who received rt-PA at a dose of 
50 mg or placebo prior to catheterization, showed 
a higher rate of patency of the vessel pre-PCI in the 
group receiving thrombolytic therapy, with increased 
left ventricular function preservation. The STREAM-
14study also showed higher pre-PCI TIMI 3 flow rates 
in patients previously submitted to thrombolysis 
(pharmaco invasive strategy).
Known predictors of failure and worse prognosis 
of PCI for myocardial infarction, the moderate/severe 
coronary calcification, and Killip class III or IV, next 
to a history of dyslipidemia, were the factors that best 
explained the occurrence of MACCE in this study.2-4,24 
Among them, the presence of more advanced Killip 
functional class raised the risk of MACCE by more 
than seven-fold.
Rescue PCI, unlike primary PCI, requires further 
studies to assess its contemporary results; however, in 
the present registry, it was shown to be a viable alter-
native for patients that did not have access to primary 
PCI and those who failed thrombolytic therapy.
Study limitations
Limitations to the present study are the retrospective 
analysis of data between two cohorts with non-adjusted 
clinical variables and the absence of late follow-up.
CONCLUSIONS
In this contemporary registry, rescue PCI showed 
similar results to those of in-hospital primary PCI.
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